We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.07B
AUM Growth
+$73.1M
Cap. Flow
+$14.8M
Cap. Flow %
1.38%
Top 10 Hldgs %
28.89%
Holding
151
New
15
Increased
70
Reduced
47
Closed
8

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$5.79M
2
KR icon
Kroger
KR
+$5.36M
3
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$4.18M
4
PNW icon
Pinnacle West Capital
PNW
+$3.77M
5
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$2.34M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$12.5M
2
GSK icon
GSK
GSK
+$8.54M
3
SCG
Scana
SCG
+$4.1M
4
MSFT icon
Microsoft
MSFT
+$813K
5
MO icon
Altria Group
MO
+$565K

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 10.72%
3 Technology 10.46%
4 Consumer Staples 8.74%
5 Industrials 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCG
151
DELISTED
Scana
SCG
– –
-84,532
Closed -$4.1M
3 4 5 6
7

Similar funds

PCG
Prosperity Consulting Group Owings Mills, Maryland $2.25B AUM 15.87% 1-Year Est. Return
PC
Port Capital Chicago, Illinois $2.25B AUM 13.28% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
SEGHC
Saudi Electronic Games Holding Co Riyadh $2.25B AUM
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
OCM
Oribel Capital Management New York $2.27B AUM 60.32% 1-Year Est. Return

GW Henssler & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, GW Henssler & Associates held 151 positions worth $1.07B, up 7.3% from $997M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

GW Henssler & Associates's Q4 2017 filing shows 15 new, 70 increased, 47 reduced and 8 closed positions. Its largest new stake was Perrigo: 67,391 shares worth $5.87M. The largest sale was Accenture, an estimated $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • GW Henssler & Associates's largest Q4 2017 buy was Perrigo: 67,391 shares worth $5.87M.
  • GW Henssler & Associates added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $4.18M increase.
  • GW Henssler & Associates's biggest Q4 2017 reduction was Accenture, cutting an estimated $12.5M.
  • GW Henssler & Associates fully exited GSK in Q4 2017, selling an estimated $8.54M.
  • GW Henssler & Associates's ten largest holdings make up 29% of its $1.07B portfolio in Q4 2017.
  • GW Henssler & Associates opened 15 new positions and closed 8 in Q4 2017.
  • GW Henssler & Associates's portfolio value rose 7.3% quarter-over-quarter to $1.07B.

Based on GW Henssler & Associates's 13F filing for Q4 2017, filed 6 Feb 2018.